1 to 15 of 20
Sort by: Date | Relevance
Title Senior Project Manager, Business Excellence About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System
Posted 1 day ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 4 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 4 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 5 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 8 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 9 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 10 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 16 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 16 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 17 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 18 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 23 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 24 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 29 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 29 days ago
Email this Job to Yourself or a Friend
Indicates required fields